Name: Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors
Start: 2022-06-01T18:00:00
End: 2022-06-01T19:00:00
Location: Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors

Date

Jun 1, 2022 - Jun 1, 2022

Time

2:00 pm - 3:00 pm

Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors
Speaker(s): Dr. Katharina Holstein

NHF's Wednesday Webinars are a free education series open to providers and community members. Register to attend and learn about the latest in research, breakthrough developments, and more.

Register for Wednesday Webinar Series